Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Isansys Lifecare Gains International Recognition for its Lifesaving Patient Monitoring Platform

21 October 2016: Abingdon, UK - Isansys Lifecare, a new generation digital healthcare company, has fought off competition from across the country to be nominated for a prestigious national innovation award which will see the company heading to Parliament later this month. The company has created the Patient Status Engine (PSE), a remarkable new patient monitoring platform which collects and analyses patients’ vital signs and will alert doctors and nurses if a person’s health is deteriorating

Read the rest of entry »

Jellagen Pty Ltd Wins the First Life Science Hub Boost Cymru Prize Worth £50,000

20 October 2016: Cardiff, UK – Jellagen Pty Ltd, a medical-technology company is pleased to announce that it was awarded the first Boost Cymru (Wales) award for Life Sciences at an awards dinner held Thursday 6th Oct in Cardiff. Boost Cymru was launched in March 2016 by the Life Sciences Hub Wales, with the aim of encouraging new ideas, products or services from businesses, organisations and individuals from across Wales that could go to market within two years. The business has been awarded a prize fund worth £50,000 thanks to sponsorship from companies including Microsoft, MSD, Greaves Brewster and GE. The winning package includes support, mentoring and funding as well as the opportunity to travel to the US to take part in a senior leadership training course with internationally renowned speakers. Jellagen entered the competition to support the product launch of the company’s new hydrogel technology platform as a new 3D cell culture assay ...

Read the rest of entry »

Brainomix Completes a £1.5 Million Investment Round

20 October 2016: Oxford, UK – Brainomix Ltd, a company developing imaging biomarkers for neurological and cerebrovascular disorders, announced today that it has completed a £1.5 million investment round. This will enable Brainomix to further commercialize its proprietary medical imaging software, e-ASPECTS, and expand its market penetration in Europe, Latin America and the United States. The round was led by Chimera Partners and Parkwalk Advisors with all existing investors participating in the investment round.

Read the rest of entry »

Fast Growing UK Synthetic Biotech Oxford Genetics Moves to The Oxford Science Park

19 October 2016: Oxford, UK - Oxford Genetics Ltd, a leading biotech which specialises in DNA design, protein expression optimisation and cell line development technologies and services, has moved its operations to new, state-of-the-art laboratories at The Oxford Science Park.

Read the rest of entry »

AMSBIO Extends and Updates its Organoid Culture Handbook

18 October 2016: Abingdon, UK - AMSBIO announces an extended and updated edition of its popular Organoid Culture Handbook. Launched at the EMBO Symposium on Organoids: Modelling Organ Development and Disease in 3D Culture, the new 24-page handbook includes valuable information about the latest available products, protocols, example results and research paper citations.

Read the rest of entry »

Oxford Immunotec Schedules Third Quarter 2016 Earnings Release and Conference Call for November 1, 2016

17 October, 2016: Oxford, UK & Marlborough, USA - Oxford Immunotec Global PLC  a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of under-served immune-regulated conditions, today announced that it plans to release third quarter 2016 financial results prior to market open on Tuesday, November 1, 2016. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast.

Read the rest of entry »

Victor Emmanuel, Senior Industry Consultant, Joins Communications Strategy Group (CSG) Advisory Board & Sandra Judd, Life Sciences and Healthcare Communications Professional Joins as Senior Consultant

17 October 2016 Boston, USA – The Communications Strategy Group Inc. (CSG), announced today that Victor J. Emmanuel, a senior public relations executive with great depth and strength in the planning of complex marketing communications and crisis management campaigns for private and public sector clients, has joined the firm’s Advisory Board. Further, that Sandra Judd, M.S., a senior marketing and public relations professional with extensive experience in nutritional sciences, healthcare and business-to-business communications, has joined the team as a Senior Consultant.

Read the rest of entry »

Wickham Laboratories Announces Renewal of FDA Accreditation

17 October 2016: Gosport, UK - Wickham Laboratories announces that the United States Food and Drug Administration (FDA) inspection conducted 15th-17th of February 2016 has now been closed out and our accreditation is renewed for a further term. This multi-day inspection assessed our compliance with Good Manufacturing Practices (GMP) and included an evaluation of our quality management system, organisation, personnel, validation and qualification procedures.

Read the rest of entry »

YProtech Secures Successful Fundraise for Specialist Chemical Technology Services Company Arranged by Acceleris Capital

14 October 2016: Macclesfield, UK - Manchester-based corporate finance house Acceleris Capital today announces that it has successfully completed an oversubscribed fundraising for YProtech Ltd.

Read the rest of entry »

Xenogesis Increases Capabilities, Adding CYP Induction and Gene Expression Assay Services to its Portfolio

14 October 2016: Nottingham, UK - XenoGesis has invested in a state of the art Agilent AriaMx Real-time PCR system, further expanding its quantitative PCR capabilities and adding CYP induction assays to its portfolio of services.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.